Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Sanara MedTech (SMTI) over the last 10 years, with Q3 2025 value amounting to $569342.0.

  • Sanara MedTech's Other Operating Expenses rose 36.07% to $569342.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 10609.62%. This contributed to the annual value of $2.0 million for FY2024, which is 94555.27% up from last year.
  • Sanara MedTech's Other Operating Expenses amounted to $569342.0 in Q3 2025, which was up 36.07% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's Other Operating Expenses peaked at $1.1 million during Q1 2025, and registered a low of -$4.2 million during Q4 2022.
  • In the last 5 years, Sanara MedTech's Other Operating Expenses had a median value of $218514.0 in 2023 and averaged -$287981.2.
  • In the last 5 years, Sanara MedTech's Other Operating Expenses crashed by 434482.05% in 2021 and then surged by 50172.6% in 2022.
  • Over the past 5 years, Sanara MedTech's Other Operating Expenses (Quarter) stood at -$3.5 million in 2021, then fell by 17.48% to -$4.2 million in 2022, then skyrocketed by 76.38% to -$983578.0 in 2023, then surged by 127.43% to $269802.0 in 2024, then soared by 111.02% to $569342.0 in 2025.
  • Its last three reported values are $569342.0 in Q3 2025, $1.1 million for Q2 2025, and $1.1 million during Q1 2025.